for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

China Medicine Health Industry Co Ltd

600056.SS

Latest Trade

13.40CNY

Change

-0.03(-0.22%)

Volume

4,461,861

Today's Range

13.37

 - 

13.50

52 Week Range

11.87

 - 

17.17

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
13.43
Open
13.45
Volume
4,461,861
3M AVG Volume
174.71
Today's High
13.50
Today's Low
13.37
52 Week High
17.17
52 Week Low
11.87
Shares Out (MIL)
1,068.49
Market Cap (MIL)
14,349.76
Forward P/E
9.37
Dividend (Yield %)
3.23

Latest Developments

More

China Meheco's H1 Net Profit Down 17.99% Y/Y

China Meheco Group's Unit Plans To Invest 206.9 Mln Yuan In Pharma Firm

China Meheco Group Says 2018 Net Profit Up 17.6 Percent Y/Y

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About China Medicine Health Industry Co Ltd

China Meheco Group Co., Ltd. is mainly engaged in the operation of industrial pharmaceutical, commercial pharmaceutical and international trading businesses. Industrial Pharmaceutical segment mainly involves in the manufacture and distribution of chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, herbal decoction pieces and other pharmaceutical products. Commercial Pharmaceutical segment is mainly engaged in the wholesale and distribution of pharmaceuticals and medical devices. Trading segment is mainly engaged in the international exporting business and medical resourcing introduction.

Industry

Medical Equipment & Supplies

Contact Info

No. 18

Guangming Middle Street

Dongcheng District

+86.10.67164267

http://www.meheco.com

Executive Leadership

Yuwen Gao

Chairman of the Board

Wenling Hou

General Manager

Hongxin Wang

Deputy General Manager, Director

Hongquan Hao

Deputy General Manager

Daming Nian

Deputy General Manager

Key Stats

1.50 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2016

25.7K

2017

30.1K

2018

31.0K

2019(E)

33.8K
EPS (CNY)

2016

0.924

2017

1.215

2018

1.446

2019(E)

1.430
Price To Earnings (TTM)
10.30
Price To Sales (TTM)
0.43
Price To Book (MRQ)
1.65
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
61.03
LT Debt To Equity (MRQ)
6.54
Return on Investment (TTM)
15.83
Return on Equity (TTM)
6.42

Latest News

BRIEF-China Meheco Sells 7.2 Million Shares In China Merchants Bank As Of Dec

* SAYS IT HAS SOLD 7.2 MILLION SHARES IN CHINA MERCHANTS BANK AS OF DEC, RECEIVES NET INVESTMENT PROFIT OF ABOUT 128 MILLION YUAN ($19.66 million) Source text in Chinese: http://bit.ly/2C7C4qp Further company coverage: ($1 = 6.5100 Chinese yuan renminbi) (Reporting by Hong...

BRIEF-China Meheco unit to set up pharmaceutical commerce JV in Hubei

* Says co's Hubei-based pharmaceutical unit plans to invest 5.1 million yuan to set up a Hubei-based pharmaceutical commerce JV, with registered capital of 10 million yuan

BRIEF-China Meheco unit to invest 5.1 mln yuan to set up hematodialysis JV in Guangdong

* Says Guangdong-based medicine unit will invest 5.1 million yuan to set up a hematodialysis JV in Guangdong and hold 51 percent stake in the JV after transaction

BRIEF-China Meheco says change of corporate auditor

* Says it plans to name Grant Thornton as corporate auditor for 2017

BRIEF-Pharmaceutical firm China Meheco's board elects chairman

China Meheco Co Ltd * Says board elects Jiang Xin as chairman Source text in Chinese: http://bit.ly/2hYjY0W Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-China Meheco unit gets approval for drug clinical trials

* Says its unit received drug clinical trials approval for its injection, which is mainly used for treatment of lung cancer and breast cancer

BRIEF-China Meheco's H1 net profit up 28.05 pct y/y at 652.65 mln yuan

* Says H1 net profit up 28.05 percent y/y at 652.65 million yuan ($97.94 million)

BRIEF-China Meheco to acquire stake in pharma firm for 286.2 mln yuan in Hainan province

* Says it plans to acquire 54 percent stake in pharma firm for 286.2 million yuan ($42.13 million) in Hainan province

BRIEF-China Meheco unit to use 7.2 mln yuan to set up medical tech JV with 2 individuals

* Says its controlling unit will set up a medical technology joint venture in Henan, which will be capitalized at 10 million yuan, with 2 individuals

BRIEF-China Meheco unit to set up medicine unit in Hubei

* Says its controlling pharmaceutical unit plans to use 10 million yuan to set up a medicine unit in Hubei

BRIEF-China Meheco expects 2016 net profit to rise 48-58 pct

* Says it expects 2016 net profit to rise 48-58 percent y/y versus net profit of 614.46 million yuan ($89.39 million) year ago

BRIEF-China Meheco unit wins lawsuit regarding contract dispute

* Says its wholly owned healthcare product unit won lawsuit against three firms regarding contract dispute

BRIEF-China Meheco unit to set up pharmaceutical unit

* Says its unit to invest 10 million yuan to set up a wholly owned pharmaceutical subsidiary

BRIEF-Pharmaceutical company China Meheco to launch up to 1 bln yuan asset-backed securities

* Says it plans to launch up to 1.0 billion yuan ($147.67 million) asset-backed securities

BRIEF-China Meheco unit gets drug registration certificate

* Says its unit received drug registration certificate from China Food and Drug Administration, for diclofenac diethylamine emulsion agent

BRIEF-China Meheco buys 45.37 pct stake in investment firm

* Says it acquired 45.37 percent stake in a Wuhan-based investment firm via private placement of share issue

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up